Non-Invasive Serum and Elastography-Based Markers of Fibrosis Staging in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review. AGDD [Internet]. 2024 Jul. 22 [cited 2026 Oct. 31];7(1):32-6. Available from: https://somatopub.com/index.php/AGDD/article/view/300